Cellebrite DI Ltd. stock is trading deep in oversold territory after a sharp post-earnings decline. CLBT closed at $10.22, far below its clustered 20, 50 and 200-day EMAs. That gap confirms a fast, disruptive move lower rather than a gradual drift.
Key takeaways
- CLBT closed at $10.22 after a sharp post-earnings decline.
- Price sits far below its 20, 50 and 200-day EMAs, which cluster between $14.62 and $14.89.
- Daily RSI14 is 23.73, deep in oversold territory.
- Daily support sits at $9.66, with resistance at $10.70.
- MACD is negative across daily, hourly and 15-minute timeframes.
Cellebrite DI Ltd. Stock: The Earnings Catalyst
Cellebrite DI missed its own annual recurring revenue expectations for the second quarter. Notably, management cited delayed large transactions and slower-than-anticipated pricing and expansion gains tied to customer migrations. It also flagged added procurement requirements around cloud and artificial intelligence.
Overall, these factors point to execution friction rather than a one-off miss. The market has repriced the stock accordingly.
Daily Structure: Oversold, But Not Yet Stabilizing
The daily chart remains bearish, with price deeply oversold but not yet stabilizing. RSI14 sits at 23.73, deep in oversold territory. MACD shows a line of -0.17 against a signal of 0.15, producing a histogram of -0.32. That is a clear bearish momentum reading.
Meanwhile, price has broken below the lower Bollinger Band at 12.43, while the mid-band sits at 14.86. A close below the lower band during a trending move usually signals momentum-driven selling rather than mean-reversion buying.
Daily ATR14 stands at 1.07, elevated relative to recent price levels near $10. That confirms volatility expanded meaningfully around the earnings event. The daily pivot sits at 10.14, with resistance at 10.70 and support at 9.66. Price is hovering just above the pivot. This puts the $9.66 level in focus as the next line of defense if selling resumes.
1H Timeframe: Confirms the Bearish Bias, Adds Urgency
The hourly chart confirms the bearish bias and adds urgency. RSI14 on the 1H sits at 8.64, an extreme oversold reading beyond the daily chart. MACD on the 1H is at -0.86 versus a signal of -0.26. The histogram of -0.59 confirms active bearish momentum. Price is also trading below the 1H lower Bollinger Band of 11.88, mirroring the daily breakdown.
The 1H EMAs (20 at 14.71, 50 at 15.21, 200 at 15.02) remain well above current price. In practice, the drop happened quickly enough that even short-term moving averages have not caught up. As a result, any near-term bounce would still face heavy overhead resistance from those lagging averages.
15m Execution Context
The 15-minute timeframe is explicitly bearish, unlike the neutral tags on daily and hourly. RSI14 at 16.25 and a widening negative MACD histogram of -0.34 support that classification. The 15m pivot sits at 10.28, with resistance at 10.34 and support at 10.16.
This is a tight range. It suggests the market is consolidating just below short-term resistance after the initial shock. For intraday positioning, this level is where the next directional move is likely to originate.
Bullish Scenario
A bounce would rest almost entirely on how stretched the oversold readings have become. RSI at 23.73 on the daily and single digits on the hourly chart are levels that historically invite short-covering or mean-reversion buying. CLBT would need to reclaim the daily pivot at 10.14. A push through 1H resistance at 10.49 could then open a relief rally toward daily r1 at $10.70.
Still, a recovery of that scale would not repair the broader trend damage. It would at least stabilize price action after the earnings-driven shock.
Bearish Scenario
The weight of evidence still favors continuation to the downside. MACD is negative across all three timeframes, and price remains below every relevant Bollinger Band. Therefore, the more likely near-term scenario is a retest of daily support at $9.66.
A breakdown below that level would invalidate any bullish bounce thesis. It would also open the door to further downside, given the fundamental headwinds around delayed transactions and slower expansion revenue.
Closing Take
Cellebrite DI Ltd. stock is in a volatile, high-uncertainty phase. Daily and hourly signals align on a bearish bias, while the 15m timeframe adds confirmation at the execution level. At the same time, oversold extremes across every timeframe mean sharp counter-trend moves are possible in either direction.
Elevated ATR readings on the daily and hourly charts reflect that volatility directly. Positioning around this name should account for wide intraday swings. The post-earnings adjustment period is still actively unfolding.
FAQ
What caused Cellebrite DI Ltd. stock to decline?
Cellebrite DI reported second-quarter results that missed its annual recurring revenue expectations. Management cited delayed large transactions and slower pricing and expansion gains tied to customer migrations. It also flagged added procurement requirements around cloud and artificial intelligence.
What are the key support and resistance levels for CLBT?
The daily pivot sits at 10.14, with resistance at 10.70 and support at 9.66. On the 15-minute chart, resistance is at 10.34 and support at 10.16.
Is CLBT oversold?
Daily RSI14 is 23.73, and hourly RSI14 is 8.64. Both readings are deep in oversold territory, which could invite short-covering or mean-reversion buying.
What is the current technical bias for CLBT?
The 15-minute timeframe is explicitly bearish. MACD is negative across daily, hourly and 15-minute charts, and price remains below all relevant Bollinger Bands.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument or cryptocurrency. The analysis provided is not indicative of future results. Investing in crypto assets and financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.
Be the first to comment